These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2564208)

  • 41. Unilateral neuroleptic-induced akathisia.
    Hermesh H; Munitz H
    Clin Neuropharmacol; 1990 Jun; 13(3):253-8. PubMed ID: 1972654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroleptic-induced akathisia treated with pindolol.
    Reiter S; Adler L; Erle S; Duncan E
    Am J Psychiatry; 1987 Mar; 144(3):383-4. PubMed ID: 2881493
    [No Abstract]   [Full Text] [Related]  

  • 43. Beta 2-receptor density on mononuclear blood cells in patients suffering from neuroleptic-induced akathisia (NIA).
    Botschev C; Bondy B; Hofmann M; Kircher T; Müller-Spahn F
    Biol Psychiatry; 1996 Aug; 40(3):203-7. PubMed ID: 8830953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Compound ICI 118,551, a beta 2-adrenoceptor antagonist, lowers blood pressure.
    Vincent HH; Man in 't Veld AJ; Boomsma F; Derkx F; Schalekamp MA
    J Hypertens Suppl; 1985 Dec; 3(3):S247-9. PubMed ID: 2908820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The 5-HT1D receptor agonist zolmitriptan for neuroleptic-induced akathisia: an open label preliminary study.
    Gross-Isseroff R; Magen A; Shiloh R; Hermesh H; Weizman A
    Int Clin Psychopharmacol; 2005 Jan; 20(1):23-5. PubMed ID: 15602112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological characterization of tardive akathisia.
    Sachdev P; Chee KY
    Biol Psychiatry; 1990 Nov; 28(9):809-18. PubMed ID: 1979500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
    Poyurovsky M; Epshtein S; Fuchs C; Schneidman M; Weizman R; Weizman A
    J Clin Psychopharmacol; 2003 Jun; 23(3):305-8. PubMed ID: 12826992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of mirtazapine in the treatment of antipsychotic-induced akathisia.
    Hieber R; Dellenbaugh T; Nelson LA
    Ann Pharmacother; 2008 Jun; 42(6):841-6. PubMed ID: 18460588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Akathisia and suicidal ideation in first-episode schizophrenia.
    Seemüller F; Schennach R; Mayr A; Musil R; Jäger M; Maier W; Klingenberg S; Heuser I; Klosterkötter J; Gastpar M; Schmitt A; Schlösser R; Schneider F; Ohmann C; Lewitzka U; Gaebel W; Möller HJ; Riedel M;
    J Clin Psychopharmacol; 2012 Oct; 32(5):694-8. PubMed ID: 22926606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of clonidine in treating neuroleptic-induced akathisia.
    Zubenko GS; Cohen BM; Lipinski JF; Jonas JM
    Psychiatry Res; 1984 Nov; 13(3):253-9. PubMed ID: 6152054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clozapine-induced akathisia in children with schizophrenia.
    Gogtay N; Sporn A; Alfaro CL; Mulqueen A; Rapoport JL
    J Child Adolesc Psychopharmacol; 2002; 12(4):347-9. PubMed ID: 12625995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of efficacy of the 5-HT3 receptor antagonist granisetron in the treatment of acute neuroleptic-induced akathisia.
    Poyurovsky M; Weizman A
    Int Clin Psychopharmacol; 1999 Nov; 14(6):357-60. PubMed ID: 10565803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clonidine in neuroleptic-induced akathisia.
    Adler LA; Angrist B; Peselow E; Reitano J; Rotrosen J
    Am J Psychiatry; 1987 Feb; 144(2):235-6. PubMed ID: 2880516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. L-tryptophan in neuroleptic-induced akathisia.
    Kramer MS; DiJohnson C; Davis P; Dewey DA; DiGiambattista S
    Biol Psychiatry; 1990 Mar; 27(6):671-2. PubMed ID: 1969752
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin.
    Miller CH; Fleischhacker WW; Ehrmann H; Kane JM
    Psychopharmacol Bull; 1990; 26(3):373-6. PubMed ID: 1980375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful treatment with clonazepam for neuroleptic-induced akathisia.
    Horiguchi J; Nishimatsu O; Inami Y
    Acta Psychiatr Scand; 1989 Jul; 80(1):106-7. PubMed ID: 2569804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for the development of neuroleptic induced akathisia.
    Miller CH; Hummer M; Oberbauer H; Kurzthaler I; DeCol C; Fleischhacker WW
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):51-5. PubMed ID: 9088885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Noradrenergic mechanisms in akathisia: treatment with propranolol and clonidine.
    Adler L; Angrist B; Peselow E; Corwin J; Rotrosen J
    Psychopharmacol Bull; 1987; 23(1):21-5. PubMed ID: 2885887
    [No Abstract]   [Full Text] [Related]  

  • 59. Placebo response in refractory tardive akathisia.
    Remington G; Fornazzari L; Sethna R
    Can J Psychiatry; 1993 May; 38(4):248-50. PubMed ID: 8100184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opioids a better treatment for acute than tardive akathisia: possible role for the endogenous opiate system in neuroleptic-induced akathisia.
    Walters AS; Hening A
    Med Hypotheses; 1989 Jan; 28(1):1-2. PubMed ID: 2564626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.